Tomorrow’s Medicine

Pediatric hematology-oncology research has come a long way and achieved significant breakthroughs – today, 80% of children diagnosed with cancer recover from this ordeal. However, 20% of children still do not respond to current treatments, and over 70% of young adult survivors of pediatric cancer face long-term side effects.

Historic $50M Commitment from the Charles-Bruneau Foundation

It is to cure the 20% of children whose cancer resists treatment, and to improve the quality of life for young people in remission so that they achieve true recovery without sequelae or complications, that the Charles-Bruneau Foundation announced, in September 2025, an unprecedented five-year commitment – $50M over five years (2025-2030) – to support research projects on childhood cancers.

This commitment revolves around a visionary approach where the collaboration and complementarity of Quebec’s four university hospital centers specializing in pediatric hematology-oncology will be prioritized, for the benefit of thousands of children and their families across Quebec.

More specifically, this commitment leverages the expertise of CHU Sainte-Justine, the Montreal Children’s Hospital, CHU de Québec-Université Laval, and CIUSSS de l’Estrie-CHUS to conduct fully complementary and harmonized work, ensuring the transfer of the most promising advancements to clinical practice.

Thanks to ongoing research, the medicine of tomorrow is truly being practiced today.

CHU Sainte-Justine

More than $11 million to support innovative research into cell-by-cell analysis of cancer and development of new treatments (targeted therapies, cellular and gene therapies). The support of Fondation Charles-Bruneau will also make it possible to deliver concrete results of previous research to patients: implementation of molecular diagnostics, support for families in psychological distress, and support for healthy lifestyle habits to reduce the risk of after-effects from cancer and its treatments.

CIUSSS de l’Estrie-CHUS

Close to $250,000 to support a pharmacist position dedicated to the development of the pediatric pharmacological research sector in the context of the CHUS's recent membership of the COG, and thus accelerate the opening of therapeutic studies. The support of Fondation Charles-Bruneau will also fund the acquisition of necessary material resources.

CHU de Québec-Université Laval

Nearly $9 million to implement a project to improve nursing support for children with cancer, in cooperation with the children and their families. This project will have an impact throughout Quebec and beyond. By adapting care to the needs of families, this research will heighten the expertise of nurses and facilitate their retention.